NYSE:HQL

Tekla Life Sciences Investors Stock Forecast

etoro logo Buy HQL
*Your capital is at risk
$18.34
+0.380 (+2.12%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of HQL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HQL to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Evaluation of Tekla Life Sciences Investors stock downgraded after the last trading session
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 12, 2026 Gain 8.20%

The Tekla Life Sciences Investors stock price gained 2.12% on the last trading day (Monday, 22nd Jun 2026), rising from $17.96 to $18.34. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.63% from a day low at $18.15 to a day high of $18.45. The price has risen in 7 of the last 10 days and is up by 8.39% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 43 thousand more shares were traded than the day before. In total, 164 thousand shares were bought and sold for approximately $3.01 million.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $18.53 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 3.49% during the next 3 months and, with a 90% probability hold a price between $17.16 and $19.18 at the end of this 3-month period.

HQL Signals & Forecast

The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $17.47 and $17.53. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 11.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Tekla Life Sciences Investors stock

Tekla Life Sciences Investors finds support from accumulated volume at $17.96 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.295 (1.63%) between high and low. For the last week, the stock has had daily average volatility of 1.56%.

Our recommended stop-loss: $17.64 (-3.80%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (HQL) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Tekla Life Sciences Investors to open at $18.31, and during the day (based on 14 day Average True Range), to move between $18.14 and $18.54, which gives a possible trading interval of +/-$0.400 (+/-2.21%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.21% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $17.96, some $0.380 (2.07%) from the current price of $18.34, our system finds the risk reward attractive.

Is Tekla Life Sciences Investors stock A Buy?

Tekla Life Sciences Investors holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $18.31 ( 0.154%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HQL Performance

Trading levels for HQL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 18.61 1.45%
R2 18.49 0.84%
R1 18.42 0.460%
Price 18.34
S1 18.20 -0.769%
S2 18.13 -1.15%
S3 18.02 -1.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 18.34
S1 17.96 -2.07%
S2 17.67 -3.65%
S3 16.27 -11.29%

HQL Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 11, 2026 May 21, 2026 Jun 30, 2026 $0.560 3.08%
2 Feb 20, 2026 Feb 20, 2026 Mar 31, 2026 $0.560 3.34%
3 Nov 21, 2025 Nov 21, 2025 Jan 12, 2026 $0.500 2.90%
4 Aug 22, 2025 Aug 22, 2025 Sep 30, 2025 $0.420 3.03%
5 May 22, 2025 May 22, 2025 Jun 30, 2025 $0.430 3.38%

FAQ

What is the symbol for Tekla Life Sciences Investors Stock and on which exchange is it traded?
The symbol for Tekla Life Sciences Investors is HQL and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Tekla Life Sciences Investors Stock?
Tekla Life Sciences Investors holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Tekla Life Sciences Investors Stock?
Tekla Life Sciences Investors Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.

What's the current price of Tekla Life Sciences Investors Stock?
As of the end of day on the Jun 22, 2026, the price of an Tekla Life Sciences Investors (HQL) share was $18.34.

What is the 52-week high and low for Tekla Life Sciences Investors Stock?
The 52-week high for Tekla Life Sciences Investors Stock is $18.46 and the 52-week low is $12.38.

What is the market capitalization of Tekla Life Sciences Investors Stock?
As of the Jun 22, 2026, the market capitalization of Tekla Life Sciences Investors is 557.683M.
Click to get the best stock tips daily for free!
ABOUT TEKLA LIFE SCIENCES INVESTORS
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries,...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE